<DOC>
	<DOCNO>NCT02043301</DOCNO>
	<brief_summary>This study aim characterize single dose pharmacokinetics PF-04950616 follow subcutaneous injection abdomen , upper arm thigh .</brief_summary>
	<brief_title>Pharmacokinetics And Relative Bioavailability Of Bococizumab ( PF-04950615 ; RN316 ) When Administered To The Abdomen , Thigh Or Upper Arm</brief_title>
	<detailed_description />
	<mesh_term>Hypercholesterolemia</mesh_term>
	<criteria>Male female subject 18 65 year age . Body Mass Index ( BMI ) â‰¤ 33 kg/m2 , total body weight 60 kg 90 kg ( 132 lbs 198 lb ) . Fasting LDLC must &gt; 130 mg/dL ( borderline high per NCEP ATP III criterion ) two qualify visit : initial screening ( Days 28 14 ) Day 7 . Poorly control type 1 type 2 diabetes mellitus ( HbA1c &gt; 9.0 % ) . History cardiovascular cerebrovascular event ( eg , MI , stroke , TIA ) relate procedure ( eg , angioplasty ) past year . Subjects meet New York Heart Association ( NYHA ) criteria congestive heart failure ( CHF ) class III IV .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>pharmacokinetics</keyword>
	<keyword>bioavailability</keyword>
	<keyword>PF-04950615</keyword>
</DOC>